Stockscreener 앱 받기
45.12
2.79%
1.09
전일 마감가:
$44.03
열려 있는:
$43.9
하루 거래량:
79,546
Relative Volume:
0.68
시가총액:
$662.69M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+4.62%
1개월 성능:
+22.66%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$43.03
$45.99
1주일 범위
$37.50
$45.99
52주 변동 폭
$15.00
$48.63
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
TECX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| TECX | 45.15 | 662.69M | 0 | 0 | 0 | 0.00 |
| VRTX | 449.72 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.06 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 595.00 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.52 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.14 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Tectonic started at outperform by Raymond James, TX45 cited (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Earns Outperform Rating from Analysts at Raymond James - MarketBeat
Tectonic Therapeutic initiated with an Outperform at Raymond James - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Price Target Raised to $69.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High Following Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Faces Challenges with Australian Subsidiary Amid Regulatory and Operational Risks - TipRanks
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up After Analyst Upgrade - Defense World
Tectonic Therapeutic Inc. Reports Q3 2024 Results - Yahoo Finance
BML Capital Management LLC Sells 254,295 Shares of Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Insiders of Tectonic Therapeutic, Inc. (NASDAQ:TECX) were rewarded after last week’s 10% gain - Simply Wall St
Tectonic Therapeutic price target raised to $79 from $55 at Wells Fargo - TipRanks
Tectonic Therapeutic Announces Positive Phase 1a Results in - GlobeNewswire
Tectonic's TX45 Shows Strong Phase 1 Results: 42% Renal Flow Boost, 20-Day Half-Life | TECX Stock News - StockTitan
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.38 - Defense World
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $68.50 - Defense World
Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives $23.83 Average PT from Analysts - Defense World
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic Therapeutic (NASDAQ:TECX) Reaches New 12-Month HighStill a Buy? - MarketBeat
Mineralys Therapeutics to Participate in Upcoming Investor Conferences - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month High – Still a Buy? - Defense World
Reviewing Tectonic Therapeutic (NASDAQ:TECX) and Mesoblast (NASDAQ:MESO) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 1-Year HighTime to Buy? - MarketBeat
X4 Pharmaceuticals (NASDAQ:XFOR) vs. Tectonic Therapeutic (NASDAQ:TECX) Critical Analysis - Defense World
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Hits New 1-Year High on Insider Buying Activity - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sets New 52-Week High Following Insider Buying Activity - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Director Acquires $10,077,000.00 in Stock - MarketBeat
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock By Investing.com - Investing.com Australia
Timothy Springer acquires $10.08 million in Tectonic Therapeutic stock - Investing.com India
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - The Manila Times
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024 - The Bakersfield Californian
Tectonic Therapeutic: Interesting CV Disease Drug Developer (NASDAQ:TECX) - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Short Interest in Tectonic Therapeutic (NASDAQ:TECX) Increases By 258.0% - MarketBeat
Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 4.5%Here's Why - MarketBeat
Vida Ventures Advisors LLC Takes $31.17 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - MarketBeat
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome - Yahoo Finance
89,029 Shares in Tectonic Therapeutic (NASDAQ:TECX) Acquired by Renaissance Technologies LLC - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Hits New 52-Week HighHere's Why - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Trading 5.8% Higher - MarketBeat
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 7% - MarketBeat
Navigating Uncertainty: Tectonic Therapeutic’s Clinical Data Volatility and Its Impact on Business Stability - TipRanks
Insider Activity Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com Nigeria
Tectonic Therapeutic director buys shares worth over $1.4 million By Investing.com - Investing.com South Africa
Timothy A. Springer Acquires 50,000 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - Defense World
Tectonic Therapeutic director buys shares worth over $1.4 million - Investing.com India
Tectonic Therapeutic Inc (TECX) 재무 분석
Tectonic Therapeutic Inc (TECX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):